These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Why is the fetal allograft not rejected? Davies CJ. J Anim Sci; 2007 Mar; 85(13 Suppl):E32-5. PubMed ID: 17040952 [Abstract] [Full Text] [Related]
4. Species diversity in the immunogenetic relationship between mother and fetus: is trophoblast insusceptibility to immunological destruction the only essential common feature for the maintenance of allogeneic pregnancy? Billington WD. Exp Clin Immunogenet; 1993 Mar; 10(2):73-84. PubMed ID: 8251182 [Abstract] [Full Text] [Related]
11. Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings. Jin LP, Zhou YH, Wang MY, Zhu XY, Li DJ. J Reprod Immunol; 2005 Apr; 65(2):133-46. PubMed ID: 15811518 [Abstract] [Full Text] [Related]
13. [Gestational immunology]. Sarafana S, Coelho R, Neves A, Costa Trindade J. Acta Med Port; 2007 Apr; 20(4):355-8. PubMed ID: 18198080 [Abstract] [Full Text] [Related]
19. Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion. von Rango U. Immunol Lett; 2008 Jan 15; 115(1):21-32. PubMed ID: 18055021 [Abstract] [Full Text] [Related]
20. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. J Reprod Immunol; 2004 Apr 15; 61(2):67-77. PubMed ID: 15063630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]